Ripretinib User Reviews & Ratings
Brand names: Qinlock
Ripretinib has an average rating of 1.0 out of 10 from a total of 1 reviews on Drugs.com. 0% of reviewers reported a positive experience, while 100% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Gastrointestinal Stromal Tumor | 1 reviews for Gastrointestinal Stromal Tumor | 5 medications | |
| Add your review | |||
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about ripretinib
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
For Gastrointestinal Stromal Tumor "For me ripretinib (Qinlock) was a total failure. I spent 5 months on this drug and my tumors mostly doubled in size in that time. The side effects were more pronounced and severe including hair loss, fatigue, weight loss than my previous time on Iminatib and Sunitinib. It was easy to use"